CALCNasdaqPharmaceutical PreparationsFiscal year ends December 31
CalciMedica, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$1.02−0.02 (-1.92%)
Close on Oct 19, 2026
- Market cap
- $17.44M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns CalciMedica's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
1 buys · 0 sales
Net bought $199.18K
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Alafi Capital Company LLC | 7,220,101 | 19.90% | 13D (active) amendment | Aug 19, 2026 |
| Philip Sawyer ("Sawyer") | 663,246 | 5.80% | 13G (passive) | Jan 23, 2024 |
| Bering Partners II GP, L.L.C. | 3,553,398 | 9.99% | 13D (active) amendment | Aug 19, 2026 |
| Steven Boyd | 3,411,361 | 9.99% | 13G (passive) | Jun 30, 2026 |
| Fred A. Middleton | 2,550,550 | 18.30% | 13D (active) | Mar 20, 2023 |
| Woodline Partners LP | 2,489,729 | 8.10% | 13G (passive) | Jun 30, 2026 |
| Jon M. Plexico | 2,149,522 | 6.00% | 13G (passive) | Aug 19, 2026 |
| Philip M Sawyer | 2,113,513 | 6.90% | 13D (active) | Jun 25, 2026 |
| Eric W. Roberts | 1,965,916 | 6.40% | 13D (active) amendment | Jun 25, 2026 |
| Alafi Capital Company, LLC | 1,583,153 | 11.30% | 13G (passive) amendment | Jul 22, 2025 |
| CVI Investments, Inc. | 1,556,081 | 5.10% | 13G (passive) | Jun 23, 2026 |
| Avenue Venture Opportunities Fund II, L.P. | 1,359,553 | 8.87% | 13G (passive) amendment | Sep 1, 2025 |
| Avenue Capital Management II, L.P. | 1,359,553 | 8.87% | 13G (passive) amendment | Sep 1, 2025 |
| Guy Levy | 1,075,856 | 7.50% | 13G (passive) amendment | Sep 30, 2025 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| A. Rachel Leheny | CHIEF EXECUTIVE OFFICER, Director | 1,061,481 | 3.11% | Sep 28, 2026 |
| Eric W. Roberts | CHIEF BUSINESS OFFICER, Director | 1,250,466 | 3.66% | Aug 21, 2026 |
| Kenneth A. Stauderman | Chief Scientific Officer | 12,944 | 0.04% | Sep 28, 2026 |
| Stephen Bardin | Chief Financial Officer | 43,000 | 0.13% | Sep 28, 2026 |
| Sudarshan Hebbar | Chief Medical Officer | 186,025 | 0.54% | Sep 28, 2026 |
| Michael J. Dunn | President and COO | 11,761 | 0.03% | Apr 7, 2026 |
| Evgeny Zaytsev | Director | 2,113,513 | 6.19% | Aug 21, 2026 |
| Robert N. Wilson | Director | 1,604,650 | 4.70% | Aug 21, 2026 |
| Frederic Guerard | Director | 111,110 | 0.33% | Aug 21, 2026 |
| Allan Shaw | Director | – | – | Aug 21, 2026 |
| Alan Glicklich | Director | – | – | Aug 21, 2026 |
| Fred A. Middleton | Director, 10% owner | 2,700,834 | 7.91% | Jun 29, 2026 |
| Capital Co Llc Alafi | 10% owner | 5,112,345 | 14.97% | Aug 24, 2026 |
| VI Beteiligungs GmbH & Co KG Sanderling | 10% owner | – | – | Nov 5, 2024 |
| Ventures Management VI Sanderling | 10% owner | – | – | Nov 5, 2024 |
| Venture Partners VI LP Sanderling | 10% owner | 2,407,172 | 7.05% | Nov 5, 2024 |
| Venture Partners VI Co Investment Fund LP Sanderling | 10% owner | – | – | Nov 5, 2024 |
| Ventures Management VII Sanderling | 10% owner | – | – | Nov 5, 2024 |
| Sanderling Ventures VII (Canada), L.P. | 10% owner | – | – | Nov 5, 2024 |
| Sanderling Ventures VII, L.P. | 10% owner | 1,640,044 | 4.80% | Nov 5, 2024 |
| VI Limited Partnership Sanderling | 10% owner | – | – | Nov 5, 2024 |
| Sanderling Ventures VII Annex Fund, L.P. | 10% owner | – | – | Nov 5, 2024 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| A. Rachel Leheny CHIEF EXECUTIVE OFFICER, Director, 10% owner | Jun 25, 2026 | Award | +186,729 | $0.80 | $149.38K | 317,655 |
| Fred A. Middleton Director, 10% owner | Jun 25, 2026 | Buy | +248,972 | $0.80 | $199.18K | 1,063,272 |
| Sudarshan Hebbar Chief Medical Officer | Jun 25, 2026 | Award | +124,486 | $0.80 | $99.59K | 186,025 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Jun 25, 2026 | Award | +186,729 | $0.80 | $149.38K | 366,435 |
| Robert N. Wilson Director | Jun 25, 2026 | Award | +1,182,621 | $0.80 | $946.10K | 1,604,650 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Sep 18, 2025 | Buy | +2,500 | $3.07 | $7.68K | 84,150 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Sep 15, 2025 | Buy | +3,400 | $2.68 | $9.11K | 81,650 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Sep 12, 2025 | Buy | +5,000 | $3.12 | $15.60K | 78,250 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Sep 9, 2025 | Buy | +2,343 | $3.15 | $7.38K | 73,250 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Aug 29, 2025 | Buy | +800 | $2.74 | $2.19K | 70,907 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Aug 28, 2025 | Buy | +9,200 | $2.86 | $26.31K | 70,107 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Aug 21, 2025 | Buy | +3,508 | $2.79 | $9.79K | 60,907 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Aug 20, 2025 | Buy | +2,000 | $2.72 | $5.44K | 57,399 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Aug 20, 2025 | Option exercise | +15,000 | $1.53 | $22.95K | 179,706 |
| Sudarshan Hebbar Chief Medical Officer | Aug 19, 2025 | Buy | +9,563 | $2.82 | $26.97K | 61,539 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Aug 19, 2025 | Buy | +1,000 | $2.79 | $2.79K | 55,399 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Aug 15, 2025 | Buy | +5,076 | $2.90 | $14.72K | 54,399 |
| Sudarshan Hebbar Chief Medical Officer | Aug 15, 2025 | Buy | +4,392 | $2.79 | $12.25K | 51,976 |
| Sudarshan Hebbar Chief Medical Officer | Aug 14, 2025 | Buy | +1,584 | $2.59 | $4.10K | 47,584 |
| Kenneth A. Stauderman Chief Scientific Officer | Jul 28, 2025 | Buy | +1,000 | $3.96 | $3.96K | 12,944 |
| Kenneth A. Stauderman Chief Scientific Officer | Jul 25, 2025 | Sale | −1,000 | $3.65 | $3.65K | 0 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Jul 22, 2025 | Buy | +1,500 | $3.78 | $5.67K | 49,323 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Jul 21, 2025 | Buy | +1,500 | $3.37 | $5.06K | 47,823 |
| A. Rachel Leheny CHIEF EXECUTIVE OFFICER, Director, 10% owner | Jul 21, 2025 | Buy | +1,000 | $3.40 | $3.40K | 3,500 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Jul 18, 2025 | Buy | +2,000 | $2.88 | $5.76K | 46,323 |
| Robert N. Wilson Director | Jul 18, 2025 | Buy | +4,500 | $2.87 | $12.92K | 422,029 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Jul 14, 2025 | Buy | +6,500 | $2.43 | $15.80K | 44,323 |
| A. Rachel Leheny CHIEF EXECUTIVE OFFICER, Director, 10% owner | Jul 14, 2025 | Buy | +2,500 | $2.47 | $6.18K | 2,500 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Jul 9, 2025 | Buy | +5,000 | $1.60 | $8.00K | 37,823 |
| Kenneth A. Stauderman Chief Scientific Officer | Jul 1, 2025 | Buy | +1,000 | $1.85 | $1.85K | 1,000 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Jun 26, 2025 | Buy | +4,500 | $1.44 | $6.48K | 32,823 |
| Stephen Bardin Chief Financial Officer | Jun 26, 2025 | Buy | +2,000 | $1.50 | $3.00K | 3,000 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Jun 11, 2025 | Buy | +5,000 | $1.85 | $9.25K | 28,323 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Jun 6, 2025 | Buy | +5,000 | $1.78 | $8.90K | 23,323 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Jun 5, 2025 | Buy | +5,100 | $1.70 | $8.67K | 18,323 |
| Stephen Bardin Chief Financial Officer | May 30, 2025 | Buy | +1,000 | $1.69 | $1.69K | 41,000 |
| Fred A. Middleton Director, 10% owner | Dec 6, 2024 | Buy | +4,800 | $2.65 | $12.72K | 36,514 |
| Fred A. Middleton Director, 10% owner | Nov 1, 2024 | Buy | +877 | $3.75 | $3.29K | 22,479 |
| Fred A. Middleton Director, 10% owner | Nov 1, 2024 | Buy | +86,867 | $3.75 | $325.75K | 814,300 |
| Fred A. Middleton Director, 10% owner | Nov 1, 2024 | Buy | +20,000 | $3.75 | $75.00K | 31,714 |
| Venture Partners VI LP Sanderling 10% owner | Nov 1, 2024 | Buy | +86,867 | $3.75 | $325.75K | 814,300 |
| Venture Partners VI LP Sanderling 10% owner | Nov 1, 2024 | Buy | +877 | $3.75 | $3.29K | 22,479 |
| Robert N. Wilson Director | Nov 1, 2024 | Buy | +53,333 | $3.75 | $200.00K | 417,529 |
| A. Rachel Leheny CHIEF EXECUTIVE OFFICER, Director, 10% owner | Nov 1, 2024 | Buy | +20,000 | $3.75 | $75.00K | 130,926 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Nov 1, 2024 | Buy | +53,333 | $3.75 | $200.00K | 164,706 |
| Michael J. Dunn President and COO | Sep 9, 2024 | Option exercise | +11,761 | $1.39 | $16.35K | 11,761 |
| A. Rachel Leheny CHIEF EXECUTIVE OFFICER, Director, 10% owner | Aug 27, 2024 | Buy | +1,000 | $4.19 | $4.19K | 110,926 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Aug 23, 2024 | Buy | +3,000 | $3.57 | $10.71K | 13,223 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Aug 23, 2024 | Buy | +2,000 | $3.58 | $7.16K | 46,894 |
| Robert N. Wilson Director | Aug 23, 2024 | Buy | +54,000 | $3.72 | $200.88K | 364,196 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Aug 21, 2024 | Buy | +5,000 | $4.04 | $20.20K | 44,894 |
| Robert N. Wilson Director | Jun 28, 2024 | Buy | +51,278 | $3.52 | $180.50K | 310,196 |
| Robert N. Wilson Director | Jun 27, 2024 | Buy | +8,443 | $3.23 | $27.27K | 258,918 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Jun 27, 2024 | Buy | +5,000 | $3.22 | $16.10K | 10,223 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Apr 2, 2024 | Buy | +3,254 | $3.90 | $12.69K | 39,894 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Apr 1, 2024 | Buy | +746 | $3.90 | $2.91K | 36,640 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Feb 5, 2024 | Award | +91,086 | $4.27 | $388.94K | 111,373 |
| Venture Partners VI LP Sanderling 10% owner | Jan 23, 2024 | Buy | +144,676 | $3.70 | $535.30K | 727,433 |
| Venture Partners VI LP Sanderling 10% owner | Jan 23, 2024 | Buy | +243,356 | $3.70 | $900.42K | 946,744 |
| Venture Partners VI LP Sanderling 10% owner | Jan 23, 2024 | Buy | +194,472 | $3.70 | $719.55K | 435,148 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.